Biogen (BIIB)
(Delayed Data from NSDQ)
$215.50 USD
+6.60 (3.16%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $215.67 +0.17 (0.08%) 7:04 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 781 - 789 ( 789 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Performance of Tysabri holds key to overall growth in near term
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Calendar Of Events.
Provider: WALL STREET ACCESS CORP.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Life Sciences - Biotechnology - Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.